Literature DB >> 8284392

Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.

B Hamm1, R F Thoeni, R G Gould, M E Bernardino, M Lüning, S Saini, A E Mahfouz, M Taupitz, K J Wolf.   

Abstract

PURPOSE: To evaluate prospectively the diagnostic accuracy of non-enhanced and gadolinium-enhanced magnetic resonance (MR) imaging in characterization of hepatic lesions.
MATERIALS AND METHODS: Fifty-five patients with benign and 52 patients with malignant focal liver lesions underwent examination at 1.5 T that comprised nonenhanced and dynamic contrast material-enhanced images. Four experienced radiologists independently read the different sets of images without and with knowledge of clinical history.
RESULTS: Receiver operating characteristic analysis showed that dynamic contrast-enhanced MR imaging added information to nonenhanced MR studies and thereby improved distinction between benign and malignant lesions (P < .05). Knowledge of clinical data further improved lesion characterization with nonenhanced and combined nonenhanced and contrast-enhanced MR imaging (P < .05).
CONCLUSION: Dynamic contrast-enhanced MR imaging is a useful adjunct for characterization of hepatic lesions. Knowledge of clinical history still has a decisive effect on interpretation of MR images of the liver.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8284392     DOI: 10.1148/radiology.190.2.8284392

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

1.  Characterisation of small hypoattenuating hepatic lesions in multi-detector CT (MDCT) in patients with underlying extrahepatic malignancy: added value of contrast-enhanced MR images.

Authors:  Song-Ee Baek; Mi-Suk Park; Hye Sook Hong; Jin Young Choi; Yong Eun Chung; Joon Seok Lim; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2010-07-09       Impact factor: 5.315

2.  Utility of 3D magnetic resonance imaging in preoperative evaluation of hepatobiliary diseases.

Authors:  R Tongdee; V R Narra; E P Oliveira; W Chapman; K M Elsayes; J J Brown
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

3.  Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial.

Authors:  Steven S Raman; Christopher Leary; David A Bluemke; Marco Amendola; Dushyant Sahani; Jeffrey D McTavish; Jeffrey Brody; Eric Outwater; Donald Mitchell; Douglas H Sheafor; Jeff Fidler; Isaac R Francis; Richard C Semelka; Kohkan Shamsi; Simone Gschwend; David R Feldman; Josy Breuer
Journal:  J Comput Assist Tomogr       Date:  2010 Mar-Apr       Impact factor: 1.826

4.  Extra-mammary findings in breast MRI.

Authors:  Pierluigi Rinaldi; M Costantini; P Belli; M Giuliani; E Bufi; R Fubelli; D Distefano; M Romani; L Bonomo
Journal:  Eur Radiol       Date:  2011-06-18       Impact factor: 5.315

5.  MR-arterioportography: a new technical approach for detection of liver lesions.

Authors:  Janine Rennert; Ernst-Michael Jung; Andreas G Schreyer; Patrick Hoffstetter; Peter Heiss; Stefan Feuerbach; Niels Zorger
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

6.  Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.

Authors:  Jeong Min Lee; Chong Soo Kim; Ji Hyun Youk; Mi Suk Lee
Journal:  Korean J Radiol       Date:  2003 Jan-Mar       Impact factor: 3.500

7.  Hepatic Abscess with Biliary Obstruction Mimicking Cholangiocarcinoma-a Case Report.

Authors:  Heejin Kwon
Journal:  J Gastrointest Cancer       Date:  2019-06

8.  Breath-hold spin-echo MR imaging for evaluation of dynamic enhancement of native and treated hepatocellular carcinoma after intravenous Gd-DTPA administration.

Authors:  R Lencioni; M Mascalchi; A Paolicchi; V Zampa
Journal:  MAGMA       Date:  1995 Sep-Dec       Impact factor: 2.310

Review 9.  Imaging of metastases to the liver.

Authors:  A E Mahfouz; B Hamm; D Mathieu
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 10.  Contrast agents for hepatic MRI.

Authors:  Giovanni Morana; Elisabetta Salviato; Alessandro Guarise
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.